Brain dopaminergic modulation associated with executive function in Parkinson's disease.

Area of Science:

• Neuroscience
• Cognitive Neurology
• Neuroimaging

Background:

• Parkinson's disease (PD) is associated with executive dysfunction, impacting action planning and inhibitory control.
• Prefrontal lobe dysfunction in PD may underlie difficulties with behavioral initiation and inhibition.
• The dopaminergic innervation of the prefrontal cortex suggests levodopa therapy might influence these cognitive deficits.

Purpose of the Study:

• To investigate the functional effects of levodopa therapy on neural activity during an executive function task in Parkinson's disease patients.
• To compare brain activation patterns in Parkinson's disease patients with and without levodopa treatment against healthy controls.

Main Methods:

• Functional magnetic resonance imaging (fMRI) was employed to assess brain activity.
• A go/no-go task was administered to nine Parkinson's disease patients and matched controls.
• Participants were scanned both with and without levodopa treatment.

Main Results:

• Despite similar task performance between patients and controls, distinct brain activation patterns emerged based on dopaminergic status.
• The drug-off state showed widespread brain activity, particularly in the bilateral caudate.
• Levodopa treatment did not fully normalize brain activation and shifted cingulate cortex activity from rostral to caudal regions.

Conclusions:

• Dopamine plays a crucial role in executive function control in Parkinson's disease.
• Levodopa therapy modulates neural activity in executive control networks in PD patients.
• Altered cingulate cortex activation patterns with levodopa suggest specific network changes.